The impact of obesity and metabolic syndrome on alcoholic liver disease

Clinics in Liver Disease

Volumn 18, Issue 1, 2014, Pages 157-163

  Chiang, Dian J ^a   McCullough, Arthur J ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Alcoholic liver disease; Diabetes; Insulin resistance; Metabolic syndrome; Obesity

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE;

ABDOMINAL OBESITY; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC LIVER DISEASE; DISEASE COURSE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INCIDENCE; INSULIN RESISTANCE; LIVER CARCINOGENESIS; LIVER CIRRHOSIS; METABOLIC SYNDROME X; MORTALITY; NONALCOHOLIC FATTY LIVER; PREVALENCE; REVIEW; SURVIVAL RATE;

ALCOHOLIC LIVER DISEASE; DIABETES; INSULIN RESISTANCE; METABOLIC SYNDROME; OBESITY;

CARCINOMA, HEPATOCELLULAR; DIABETES COMPLICATIONS; DISEASE PROGRESSION; HUMANS; LIVER DISEASES, ALCOHOLIC; LIVER NEOPLASMS; METABOLIC SYNDROME X; OBESITY; RISK FACTORS;

EID: 84888042245     PISSN: 10893261     EISSN: 15578224     Source Type: Journal    
DOI: 10.1016/j.cld.2013.09.006     Document Type: Review

References (38)

1. Mandayam S., Jamal M.M., Morgan T.R. Epidemiology of alcoholic liver disease. Semin Liver Dis 2004, 24(3):217-232.
2. Peery A.F., Dellon E.S., Lund J., et al. Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology 2012, 143(5):1179-1187.e1-3.
3. Mann R.E., Smart R.G., Govoni R. The epidemiology of alcoholic liver disease. Alcohol Res Health 2003, 27(3):209-219.
4. Corrao G., Ferrari P., Zambon A., et al. Are the recent trends in liver cirrhosis mortality affected by the changes in alcohol consumption? Analysis of latency period in European countries. JStud Alcohol 1997, 58(5):486-494.
5. Kim W.R., Brown R.S., Terrault N.A., et al. Burden of liver disease in the United States: summary of a workshop. Hepatology 2002, 36(1):227-242.
6. Diehl A.M. Alcoholic liver disease: natural history. Liver Transpl Surg 1997, 3(3):206-211.
7. Sorensen T.I., Orholm M., Bentsen K.D., et al. Prospective evaluation of alcohol abuse and alcoholic liver injury in men as predictors of development of cirrhosis. Lancet 1984, 2(8397):241-244.
8. Teli M.R., Day C.P., Burt A.D., et al. Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver. Lancet 1995, 346(8981):987-990.
9. Naveau S., Giraud V., Borotto E., et al. Excess weight risk factor for alcoholic liver disease. Hepatology 1997, 25(1):108-111.
10. Deleuran T., Gronbaek H., Vilstrup H., et al. Cirrhosis and mortality risks of biopsy-verified alcoholic pure steatosis and steatohepatitis: a nationwide registry-based study. Aliment Pharmacol Ther 2012, 35(11):1336-1342.
11. Orrego H., Blake J.E., Blendis L.M., et al. Prognosis of alcoholic cirrhosis in the presence and absence of alcoholic hepatitis. Gastroenterology 1987, 92(1):208-214.
12. Jepsen P., Ott P., Andersen P.K., et al. Clinical course of alcoholic liver cirrhosis: a Danish population-based cohort study. Hepatology 2010, 51(5):1675-1682.
13. Morgan M.Y. The prognosis and outcome of alcoholic liver disease. Alcohol Alcohol Suppl 1994, 2:335-343.
14. O'Shea R.S., Dasarathy S., McCullough A.J., Practice Guideline Committee of the American Association for the Study of Liver Diseases, Practice Parameters Committee of the American College of Gastroenterology Alcoholic liver disease. Hepatology 2010, 51(1):307-328.
15. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults-the evidence report. National Institutes of Health. Obes Res 1998, 6(Suppl 2):51S-209S.
16. Loomba R., Bettencourt R., Barrett-Connor E. Synergistic association between alcohol intake and body mass index with serum alanine and aspartate aminotransferase levels in older adults: the Rancho Bernardo Study. Aliment Pharmacol Ther 2009, 30(11-12):1137-1149.
17. Iturriaga H., Bunout D., Hirsch S., et al. Overweight as a risk factor or a predictive sign of histological liver damage in alcoholics. Am J Clin Nutr 1988, 47(2):235-238.
18. Everitt H., Hu M., Ajmo J.M., et al. Ethanol administration exacerbates the abnormalities in hepatic lipid oxidation in genetically obese mice. Am J Physiol Gastrointest Liver Physiol 2013, 304(1):G38-G47.
19. Tilg H., Moschen A.R. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nature reviews. Immunology 2006, 6(10):772-783.
20. Sebastian B.M., Roychowdhury S., Tang H., et al. Identification of a cytochrome P4502E1/Bid/C1q-dependent axis mediating inflammation in adipose tissue after chronic ethanol feeding to mice. JBiol Chem 2011, 286(41):35989-35997.
21. Pravdova E., Fickova M. Alcohol intake modulates hormonal activity of adipose tissue. Endocr Regul 2006, 40(3):91-104.
22. Reaven G.M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988, 37(12):1595-1607.
23. Eckel R.H., Grundy S.M., Zimmet P.Z. The metabolic syndrome. Lancet 2005, 365(9468):1415-1428.
24. Ogden C.L., Flegal K.M., Carroll M.D., et al. Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA 2002, 288(14):1728-1732.
25. Ford E.S., Giles W.H., Dietz W.H. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002, 287(3):356-359.
26. Stepanova M., Rafiq N., Younossi Z.M. Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study. Gut 2010, 59(10):1410-1415.
27. Hart C.L., Morrison D.S., Batty G.D., et al. Effect of body mass index and alcohol consumption on liver disease: analysis of data from two prospective cohort studies. BMJ 2010, 340:c1240.
28. Franceschi S., Montella M., Polesel J., et al. Hepatitis viruses, alcohol, and tobacco in the etiology of hepatocellular carcinoma in Italy. Cancer Epidemiol Biomarkers Prev 2006, 15(4):683-689.
29. Hassan M.M., Hwang L.Y., Hatten C.J., et al. Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology 2002, 36(5):1206-1213.
30. Marrero J.A., Fontana R.J., Su G.L., et al. NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States. Hepatology 2002, 36(6):1349-1354.
31. Loomba R., Yang H.I., Su J., et al. Synergism between obesity and alcohol in increasing the risk of hepatocellular carcinoma: a prospective cohort study. Am J Epidemiol 2013, 177(4):333-342.
32. Ascha M.S., Hanouneh I.A., Lopez R., et al. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology 2010, 51(6):1972-1978.
33. Bank S. Chronic pancreatitis: clinical features and medical management. Am J Gastroenterol 1986, 81(3):153-167.
34. Iversen J., Vilstrup H., Tygstrup N. Kinetics of glucose metabolism in relation to insulin concentrations in patients with alcoholic cirrhosis and in healthy persons. Gastroenterology 1984, 87(5):1138-1143.
35. Yokoyama A., Matsushita S., Ishii H., et al. The impact of diabetes mellitus on the prognosis of alcoholics. Alcohol Alcohol 1994, 29(2):181-186.
36. Torisu Y., Ikeda K., Kobayashi M., et al. Diabetes mellitus increases the risk of hepatocarcinogenesis in patients with alcoholic cirrhosis: a preliminary report. Hepatol Res 2007, 37(7):517-523.
37. Yokoyama A., Takagi T., Ishii H., et al. Impaired autonomic nervous system in alcoholics assessed by heart rate variation. Alcohol Clin Exp Res 1991, 15(5):761-765.
38. Ewing D.J., Campbell I.W., Clarke B.F. The natural history of diabetic autonomic neuropathy. QJ Med 1980, 49(193):95-108.